Arylsulfatase is an impurity found in lactase that converts components naturally present in milk to cause off-flavour in lactose-free dairy products, resulting in a limited shelf life. Adding arylsulfatase-free Maxilact to a dairy formulation ensures that off-flavour development is no longer an issue and the shelf life can be extended.
“DSM is delighted to have been granted this patent,” said Merel Roes, marketing manager, Maxilact. “It rewards our longstanding scientific efforts and investments to improve lactose-free products. Maxilact is our promise to our customers to develop stable lactose-free dairy products without any off-flavours.
“The lactose-free dairy market continues to expand globally and we see a rapid growth in overseas exports. This requires a longer shelf life and is thereby putting extra demands on enzyme quality. With Maxilact, our customers are able to deliver on their brand promise, no matter where in the world the consumer is located.”
Source: DSM
© FoodBev Media Ltd 2024